Ideaya Biosciences Inc (NASDAQ: IDYA) on Tuesday, soared 1.69% from the previous trading day, before settling in for the closing price of $40.32. Within the past 52 weeks, IDYA’s price has moved between $20.90 and $47.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 14.24% over the last five years. The company achieved an average annual earnings per share of -17.65%. With a float of $67.56 million, this company’s outstanding shares have now reached $75.69 million.
The firm has a total of 124 workers. Let’s measure their productivity.
Ideaya Biosciences Inc (IDYA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ideaya Biosciences Inc is 10.74%, while institutional ownership is 97.71%. The most recent insider transaction that took place on May 16 ’24, was worth 1,439,754. In this transaction President and CEO of this company sold 34,433 shares at a rate of $41.81, taking the stock ownership to the 677,887 shares. Before that another transaction happened on May 15 ’24, when Company’s President and CEO sold 83,856 for $42.90, making the entire transaction worth $3,597,756. This insider now owns 677,887 shares in total.
Ideaya Biosciences Inc (IDYA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -17.65% per share during the next fiscal year.
Ideaya Biosciences Inc (NASDAQ: IDYA) Trading Performance Indicators
Ideaya Biosciences Inc (IDYA) is currently performing well based on its current performance indicators. A quick ratio of 28.42 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 200.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.00, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Ideaya Biosciences Inc (IDYA)
Analysing the last 5-days average volume posted by the [Ideaya Biosciences Inc, IDYA], we can find that recorded value of 0.83 million was better than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 15.21%. Additionally, its Average True Range was 1.62.
During the past 100 days, Ideaya Biosciences Inc’s (IDYA) raw stochastic average was set at 52.82%, which indicates a significant increase from 25.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.91% in the past 14 days, which was lower than the 39.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.83, while its 200-day Moving Average is $35.43. Now, the first resistance to watch is $42.17. This is followed by the second major resistance level at $43.33. The third major resistance level sits at $44.47. If the price goes on to break the first support level at $39.87, it is likely to go to the next support level at $38.73. Should the price break the second support level, the third support level stands at $37.57.
Ideaya Biosciences Inc (NASDAQ: IDYA) Key Stats
Market capitalization of the company is 3.10 billion based on 75,687K outstanding shares. Right now, sales total 23,390 K and income totals -112,960 K. The company made 3,920 K in profit during its latest quarter, and -33,950 K in sales during its previous quarter.
